Evatanepag (CP-533536)|cas 223488-57-1

Evatanepag (CP-533536)|cas 223488-57-1

Evatanepag (CP-533536) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.

Product name: Evatanepag (CP-533536)|Purity>98%| CAS: 223488-57-1|Molecule Formular: C25H28N2O5S|MW: 468.57|Other Namess: CP-533536,CP 533536,CP533536

CP-533536 is a potent and selective EP2agonist. CP-533536 demonstrates the ability to heal fractures when administered locally as a single dose in rat models of fracture healing. CP-533536 demonstrates excellent in vitro potency against EP2 and selectivity against a broad panel of other targets.

For research only, not for human use.